Skip to main content

Phibro Animal Health Corp

PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001069899

No open-market purchases or sales by Phibro Animal Health Corp insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $660.4M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Phibro Animal Health Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of PAHC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1411147+7
Shares20.1M3.50M20.3M+3.67M (+22.1%)
Value$337.5M$58.8M$456.8M+$178.2M (+63.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Phibro Animal Health Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to PAHC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.3,588,499$80.8M0.00%
Parkwood LLC554,251$12.5M1.52%
Crawford Investment Counsel Inc165,645$3.73M0.06%
LPL Financial LLC52,393$1.18M0.00%
ExodusPoint Capital Management, LP20,800$468.0K0.00%
Sterling Capital Management LLC18,314$412.4K0.01%
Allianz Asset Management GmbH15,000$337.8K0.00%
Cerity Partners LLC13,662$307.7K0.00%
AJOVista, LLC12,741$286.9K1.23%
SG Americas Securities, LLC12,256$276.0K0.00%
Zacks Investment Management12,158$273.8K0.00%
Susquehanna International Group, LLP11,833$266.5K0.00%
nVerses Capital, LLC3,100$69.8K0.03%
Quantbot Technologies LP3,098$69.8K0.00%
Riverview Trust Co1,052$23.7K0.02%
Capital Performance Advisors LLP373$8.40K0.00%
True Wealth Design, LLC318$7.16K0.00%
Harbor Capital Advisors, Inc.167$4.00K0.00%
Ronald Blue Trust, Inc.86$1.44K0.00%
Continuum Advisory, LLC52$1.29K0.00%
Umb Bank N A16$3600.00%

Sold out (14)

Institutions that held Phibro Animal Health Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of PAHC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Hotchkis & Wiley Capital Management LLC346,360$5.81M
Citadel Advisors LLC66,192$1.11M
First Trust Advisors LP57,143$958.3K
Factorial Partners, LLC56,000$939.1K
Trexquant Investment LP38,377$643.6K
Truist Financial Corp18,371$308.1K
Squarepoint Ops LLC13,582$227.8K
Cubist Systematic Strategies, LLC10,769$180.6K
Clear Street Markets LLC4,966$83.0K
Point72 Asia (Singapore) Pte. Ltd.3,031$50.8K
Point72 (DIFC) Ltd1,454$24.4K
Catalyst Funds Management Pty Ltd400$6.71K
Quarry LP268$4.49K
Innealta Capital, LLC34$570

Not filed for Q3 2024 yet (1)

Institutions that held Phibro Animal Health Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PAHC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.3,504,466$58.8M